As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...

Treatment for liver fibrosis may involve managing the underlying cause. There sometimes is a need for a liver transplant.

what it means for the clinical management and treatment of fatty liver, and the need for new MAFLD disease models. The conversation was led by Hirokazu Takahashi, a physician specializing in ...

Patients with biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis who received a novel ...

Semaglutide (Wegovy) improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) and led ...

Hepatic steatosis steadily increased in patients with HIV and HCV coinfection despite curative treatment with DAA therapy.

The Fibrosis-4 Index (FIB-4) is used to identify adults who don’t have ... 2 There are currently no treatments approved for ...

Patients in the treatment arms received 1 mg, 2.5 mg, 5 mg or 10 mg doses. After 52 weeks of treatment, patients taking the ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

Carisma Therapeutics Inc. (CARM) presented promising preclinical data on engineered macrophages for treating liver fibrosis at the ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver fibrosis by all of three ...